Chimerix Inc banner

Chimerix Inc
NASDAQ:CMRX

Watchlist Manager
Chimerix Inc Logo
Chimerix Inc
NASDAQ:CMRX
Watchlist
Price: 8.54 USD -0.12%
Market Cap: $801.1m

Wall Street
Price Targets

CMRX Price Targets Summary
Chimerix Inc

There are no price targets for CMRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Chimerix Inc Competitors:
Price Targets
STRO
Sutro Biopharma Inc
52% Upside
FLB
Fluidigm Corp
64% Upside
EOLS
Evolus Inc
269% Upside
VAC
Pierre et Vacances SA
42% Upside
OFIX
Orthofix Medical Inc
49% Upside
SPWH
Sportsmans Warehouse Holdings Inc
143% Upside
NYXH
Nyxoah SA
241% Upside

Revenue
Forecast

-34% / Year
Past Growth
757% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-34% / Year
Past Growth
757% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 8 years the compound annual growth rate for Chimerix Inc's revenue is -34%. The projected CAGR for the next 3 years is 757%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CMRX's stock price target?
Not Available

CMRX doesn't have any price targets made by Wall Street professionals.

What is Chimerix Inc's Revenue forecast?
Projected CAGR
757%

For the last 8 years the compound annual growth rate for Chimerix Inc's revenue is -34%. The projected CAGR for the next 3 years is 757%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett